# A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants

> **NCT05615012** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 76 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986322
- **DRUG:** Rosuvastatin
- **DRUG:** Metformin
- **DIETARY_SUPPLEMENT:** Glucose
- **DRUG:** Methotrexate
- **DRUG:** Leucovorin

## Key facts

- **NCT ID:** NCT05615012
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-11
- **Primary completion:** 2023-12-13
- **Final completion:** 2023-12-13
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05615012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05615012, "A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05615012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*